GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Demant AS (OTCPK:WILLF) » Definitions » EV-to-EBIT

WILLF (Demant AS) EV-to-EBIT : 17.21 (As of May. 20, 2025)


View and export this data going back to . Start your Free Trial

What is Demant AS EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Demant AS's Enterprise Value is $10,705 Mil. Demant AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was $622 Mil. Therefore, Demant AS's EV-to-EBIT for today is 17.21.

The historical rank and industry rank for Demant AS's EV-to-EBIT or its related term are showing as below:

WILLF' s EV-to-EBIT Range Over the Past 10 Years
Min: 14.14   Med: 22.92   Max: 68.82
Current: 16.34

During the past 13 years, the highest EV-to-EBIT of Demant AS was 68.82. The lowest was 14.14. And the median was 22.92.

WILLF's EV-to-EBIT is ranked better than
57.21% of 458 companies
in the Medical Devices & Instruments industry
Industry Median: 19.705 vs WILLF: 16.34

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Demant AS's Enterprise Value for the quarter that ended in Dec. 2024 was $9,947 Mil. Demant AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was $622 Mil. Demant AS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 6.25%.


Demant AS EV-to-EBIT Historical Data

The historical data trend for Demant AS's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Demant AS EV-to-EBIT Chart

Demant AS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45.29 24.45 18.26 18.40 16.24

Demant AS Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.26 - 18.40 - 16.24

Competitive Comparison of Demant AS's EV-to-EBIT

For the Medical Devices subindustry, Demant AS's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Demant AS's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Demant AS's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Demant AS's EV-to-EBIT falls into.


;
;

Demant AS EV-to-EBIT Calculation

Demant AS's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=10704.783/621.872
=17.21

Demant AS's current Enterprise Value is $10,705 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Demant AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was $622 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Demant AS  (OTCPK:WILLF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Demant AS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2024 ) =EBIT / Enterprise Value (Q: Dec. 2024 )
=621.872/9946.87556
=6.25 %

Demant AS's Enterprise Value for the quarter that ended in Dec. 2024 was $9,947 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Demant AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was $622 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Demant AS EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Demant AS's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Demant AS Business Description

Address
Kongebakken 9, Smorum, DNK, 2765
Demant AS is a Denmark-based company engaged in the healthcare industry. The company develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Group focuses on four business areas: Hearing Devices, including such brands as Bernafon, Oticon, Frontrow, Phonic Ear and Sonic; Hearing Implants, including Oticon Medical; Diagnostic Instruments. The Company operates through more than 90 subsidiaries and associates all around the world. More than 80% of the company's sales come from North America and Europe.